Charles Chen – Vice Chairman & CEO, Medigen Vaccine Biologics Corp.…
Charles Chen of Taiwanese firm Medigen Vaccines Biologics Corp (MVC) shares his career journey, the company’s…
Address: 3F, 168, Sung Chiang Road, Taipei 104, Taiwan
Tel: (02)2568-1380
Servier is the leading French independent pharmaceutical company worldwide with products achieving a combined annual turnover of Euro 2.0 billion. We are very much a research-based company and we invest 25% of our consolidated turnover each year into R&D.
Servier Taiwan was established in 1986, the young, dynamic Taiwan team is highly successful in the marketing of products for metabolic and cardiovascular indications. Servier Taiwan plans to launch at least one new product per year for the coming five years.
Charles Chen of Taiwanese firm Medigen Vaccines Biologics Corp (MVC) shares his career journey, the company’s…
Johnsee Lee and Eric Yang of Taiwanese precision medicine diagnostics firm Quark Biosciences outline their…
Louis Cheng, CEO of Taiwanese firm Leadgene Biomedical, introduces the company’s expertise in antibody…
Taiwan Bio Industry Organization Chairman Dr Johnsee Lee outlines the Taiwanese biopharmaceutical industry’s…
Taiwan, although small in size, boasts a strong culture of innovation as well as a universal healthcare system that…
Long overshadowed by larger and more well-known neighbours, the island of Taiwan is nonetheless cultivating an…
While Taiwanese pharmaceutical and biotech players have traditionally set their sights on the US as a key market,…
All country managers of multinational pharma companies need to strike the balance between having a global outlook…
Nutrarex Biotech is a Taiwanese private label contract manufacturer of functional supplements, exclusively…
In an effort to enhance trade and cooperation with other countries in the region and reduce dependency on mainland…
Within Taiwan’s evolving medical device sector, many innovative startups are exploring breakthrough ideas which…
Mark Yang, CEO of GaleMed, elaborates on the medical device manufacturer’s transition from a privately-owned…